|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.195 EUR | -1.24% |
|
-14.46% | -21.79% |
| Capitalization | 139M 161M 126M 121M 220M 14.84B 230M 1.49B 595M 7.11B 606M 593M 25.45B | P/E ratio 2025 * |
-1.64x | P/E ratio 2026 * | -1.73x |
|---|---|---|---|---|---|
| Enterprise value | 136M 157M 122M 117M 214M 14.45B 224M 1.45B 580M 6.93B 590M 578M 24.79B | EV / Sales 2025 * |
15.7x | EV / Sales 2026 * | 7.91x |
| Free-Float |
51.64% | Yield 2025 * |
-
| Yield 2026 * | 30.9% |
Last Transcript: Nyxoah SA
| 1 day | -1.24% | ||
| 1 week | -14.46% | ||
| Current month | -14.34% | ||
| 1 month | -18.70% | ||
| 3 months | -25.35% | ||
| 6 months | -35.06% | ||
| Current year | -21.79% |
| 1 week | 3.15 |  | 3.7 |
| 1 month | 3.15 | | 4.18 |
| Current year | 3.15 | | 4.74 |
| 1 year | 3.15 | | 11.15 |
| 3 years | 3.15 | | 17.6 |
| 5 years | 3.15 | | 30 |
| 10 years | 3.15 | | 30 |
| Manager | Title | Age | Since |
|---|---|---|---|
Olivier Taelman
CEO | Chief Executive Officer | 56 | 2019-10-31 |
John Landry
DFI | Director of Finance/CFO | 54 | 2024-11-03 |
Maurits Boon
CTO | Chief Tech/Sci/R&D Officer | - | 2024-04-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Taub
CHM | Chairman | 80 | 2009-07-14 |
Kevin Rakin
BRD | Director/Board Member | 65 | 2016-06-28 |
Pierre Gianello
BRD | Director/Board Member | 70 | 2018-03-26 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.24% | -14.46% | -66.37% | -35.58% | 161M | |
| -3.03% | -3.43% | -4.63% | -9.90% | 193B | |
| -1.32% | -2.85% | -9.17% | +108.30% | 176B | |
| -2.58% | -6.66% | -8.47% | -21.31% | 143B | |
| -1.56% | -6.60% | -28.79% | +50.36% | 108B | |
| -0.22% | -4.11% | -23.32% | -20.20% | 52.25B | |
| -2.28% | -5.49% | +13.82% | +3.71% | 48.72B | |
| -1.03% | -1.46% | +12.21% | +15.22% | 37.19B | |
| -2.36% | -10.52% | -11.71% | -1.66% | 35.14B | |
| -1.68% | -4.57% | -8.47% | -19.13% | 33.38B | |
| Average | -1.76% | -3.27% | -13.49% | +6.98% | 82.71B | |
| Weighted average by Cap. | -2.03% | -1.88% | -9.23% | +22.48% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 8.61M 9.99M 7.77M 7.46M 13.6M 918M 14.23M 91.88M 36.81M 440M 37.48M 36.68M 1.57B | 29.37M 34.06M 26.51M 25.44M 46.39M 3.13B 48.55M 313M 126M 1.5B 128M 125M 5.37B |
| Net income | -89.02M -103M -80.36M -77.11M -141M -9.49B -147M -950M -381M -4.55B -387M -379M -16.27B | -105M -122M -94.97M -91.12M -166M -11.21B -174M -1.12B -450M -5.38B -458M -448M -19.23B |
| Net Debt | -3.6M -4.18M -3.25M -3.12M -5.69M -384M -5.95M -38.42M -15.39M -184M -15.67M -15.34M -658M | 93.08M 108M 84.03M 80.62M 147M 9.92B 154M 993M 398M 4.76B 405M 397M 17.02B |
Employees
184
Calendar
03-19 -
Earnings release - Annual 2025
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-06 | 3.195 € | -1.24% | 53,166 |
| 26-03-05 | 3.235 € | -5.13% | 169,062 |
| 26-03-04 | 3.410 € | +1.49% | 61,480 |
| 26-03-03 | 3.360 € | -6.67% | 100,025 |
| 26-03-02 | 3.600 € | -3.49% | 56,130 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.235EUR
Average target price
9.500EUR
Spread / Average Target
+193.66%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NYXH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition